trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['trastuzumab', 'congrat', 'breast']
in concurrent with #asco22 plenary:
trastuzumab deruxtecan in previously treated her2-low advanced breast cancer finally a meaningful therapy for her-2 low #breastcancer congratulations and colleagues.
Pancreatic cancer researcher and GI pathologist. Striving to improve the lives of patients with cancer.